Cormorant Asset Management’s Opus Genetics IRD Stock Holding History
Bought
Maintained
Sold
Other funds holding IRD
Cormorant Asset Management's IRD Position: Q3 2026 in Review
Cormorant Asset Management opened a new position in Opus Genetics (IRD) in Q3 2026: 5,500,000 shares worth $26.6M. The stake represents 1.79% of the portfolio and ranks #19 among its holdings.
97 funds tracked by Wall St. Rank hold IRD as of Q3 2026.
- Cormorant Asset Management held 5,500,000 shares of Opus Genetics worth $26.6M as of Q3 2026.
- Opus Genetics was a new Cormorant Asset Management position in Q3 2026.
- Opus Genetics made up 1.79% of Cormorant Asset Management's portfolio in Q3 2026, its #19 holding.
- 97 funds tracked by Wall St. Rank held Opus Genetics as of Q3 2026.
Based on Cormorant Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.